TFFP
Price:
$0.065
Market Cap:
$288.80K
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's lead drug candidates are TFF Voriconazole Inhalation Powder, which is in Phase II clinical trials for the treatment of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder, which is in Phase II clinical trials used to prevent lung transplant rejection. It is also developing other dry powder products, such as canna...[Read more]
Industry
Biotechnology
IPO Date
2019-10-25
Stock Exchange
NASDAQ
Ticker
TFFP
According to TFF Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -2265301.00. This represents a change of -128.42% compared to the average of 7.97M of the last 4 quarters.
The mean historical Enterprise Value of TFF Pharmaceuticals, Inc. over the last ten years is 352.17M. The current -2265301.00 Enterprise Value has changed -164.32% with respect to the historical average. Over the past ten years (40 quarters), TFFP's Enterprise Value was at its highest in in the September 2020 quarter at 9.59B. The Enterprise Value was at its lowest in in the March 2018 quarter at 0.
Average
352.17M
Median
49.17M
Minimum
0
Maximum
2.26B
Discovering the peaks and valleys of TFF Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Enterprise Value = 2.26B
Minimum Annual Increase = -96.31%
Minimum Annual Enterprise Value = 0
Year | Enterprise Value | Change |
---|---|---|
2023 | 7.22M | -52.04% |
2022 | 15.06M | -91.92% |
2021 | 186.37M | -27.54% |
2020 | 257.19M | 2.81% |
2019 | 8.85M | -89.38% |
2018 | 83.28M | -96.31% |
2017 | 2.26B | Infinity% |
The current Enterprise Value of TFF Pharmaceuticals, Inc. (TFFP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
69.55M
5-year avg
94.94M
10-year avg
352.17M
TFF Pharmaceuticals, Inc.’s Enterprise Value is less than Gain Therapeutics, Inc. (30.36M), less than aTyr Pharma, Inc. (138.44M), less than IN8bio, Inc. (18.87M), less than Lantern Pharma Inc. (24.76M), less than INmune Bio, Inc. (70.25M), less than Anebulo Pharmaceuticals, Inc. (31.01M), less than Abcam plc (134.60M), less than AN2 Therapeutics, Inc. (8.33M), less than Anixa Biosciences, Inc. (82.04M), less than Immunome, Inc. (531.87M), less than Annovis Bio, Inc. (48.90M), less than Cognition Therapeutics, Inc. (4.08M), less than TScan Therapeutics, Inc. (117.88M), less than Cue Biopharma, Inc. (42.98M), greater than Dermata Therapeutics, Inc. (-3633607.00), less than Oncorus, Inc. (42.71M), less than Orgenesis Inc. (25.78M), less than Quoin Pharmaceuticals, Ltd. (-480796.00), greater than Apexigen, Inc. (-5121682.00),
Company | Enterprise Value | Market cap |
---|---|---|
30.36M | $41.64M | |
138.44M | $131.12M | |
18.87M | $17.40M | |
24.76M | $32.57M | |
70.25M | $100.88M | |
31.01M | $32.42M | |
134.60M | $5.52B | |
8.33M | $41.83M | |
82.04M | $83.02M | |
531.87M | $684.71M | |
48.90M | $61.54M | |
4.08M | $25.51M | |
117.88M | $160.65M | |
42.98M | $65.88M | |
-3633607.00 | $2.51M | |
42.71M | $0 | |
25.78M | $8.68M | |
-480796.00 | $2.64M | |
-5121682.00 | $9.57M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TFF Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like TFF Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is TFF Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for TFF Pharmaceuticals, Inc. (TFFP)?
What is the 3-year average Enterprise Value for TFF Pharmaceuticals, Inc. (TFFP)?
What is the 5-year average Enterprise Value for TFF Pharmaceuticals, Inc. (TFFP)?
How does the current Enterprise Value for TFF Pharmaceuticals, Inc. (TFFP) compare to its historical average?